Effects of Head Elevation by a Bed on Sleep-disordered Breathing
NCT ID: NCT01785199
Last Updated: 2013-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
60 participants
INTERVENTIONAL
2013-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using an automatic adjustable bed will improve sleep-disordered breathing with a reduction of AHI score is assumed. The minimal sample size is estimated to be 14 subjects per group with the intention of providing 80% power and an overall two-sided 5% type I error. A total of 60 subjects (15 subjects per group) will be enrolled to achieve the necessary number of evaluable subjects, anticipating roughly a 10% drop-out rate.
Informed written consent will be obtained from all subjects. This study was approved by the Mackay Memorial Hospital Institutional Review Board.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal (AHI < 5)
Patients who are eligible for this study will sleep on an automatic adjustable bed with a second PSG performed within the next one month.
Head elevation by an automatic adjustable bed
The automatic device is initiated when the patient suffers from apnea ≥ 10 seconds, which is detected by an ultra-wideband (UWB) sensor placed under the bed. The head will be slightly elevated at an angle of 10 degrees lasting 10 seconds and then be put down softly.
mild OSA (AHI between 5 and 15)
Patients who are eligible for this study will sleep on an automatic adjustable bed with a second PSG performed within the next one month.
Head elevation by an automatic adjustable bed
The automatic device is initiated when the patient suffers from apnea ≥ 10 seconds, which is detected by an ultra-wideband (UWB) sensor placed under the bed. The head will be slightly elevated at an angle of 10 degrees lasting 10 seconds and then be put down softly.
moderate OSA (AHI between 15 and 30)
Patients who are eligible for this study will sleep on an automatic adjustable bed with a second PSG performed within the next one month.
Head elevation by an automatic adjustable bed
The automatic device is initiated when the patient suffers from apnea ≥ 10 seconds, which is detected by an ultra-wideband (UWB) sensor placed under the bed. The head will be slightly elevated at an angle of 10 degrees lasting 10 seconds and then be put down softly.
severe OSA (AHI > 30)
Patients who are eligible for this study will sleep on an automatic adjustable bed with a second PSG performed within the next one month.
Head elevation by an automatic adjustable bed
The automatic device is initiated when the patient suffers from apnea ≥ 10 seconds, which is detected by an ultra-wideband (UWB) sensor placed under the bed. The head will be slightly elevated at an angle of 10 degrees lasting 10 seconds and then be put down softly.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Head elevation by an automatic adjustable bed
The automatic device is initiated when the patient suffers from apnea ≥ 10 seconds, which is detected by an ultra-wideband (UWB) sensor placed under the bed. The head will be slightly elevated at an angle of 10 degrees lasting 10 seconds and then be put down softly.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Psychiatric disorders
* Clinical instability in the previous month
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seda Chemical Products Co., Ltd.
UNKNOWN
Mackay Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ching-Lung Liu
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ching-Lung Liu, MD
Role: PRINCIPAL_INVESTIGATOR
Sleep Center, Mackay Memorial Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mackay Memorial Hospital, Tamshui Branch
New Taipei City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ching-Lung Liu, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UWB-C-008
Identifier Type: -
Identifier Source: org_study_id